TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Australia expects to receive AstraZeneca's COVID-19 vaccine within months
Change Size
A shopkeeper stands at his market booth in the city centre as the state of New South Wales continues to report relatively low numbers for new daily cases of the COVID-19, in Sydney, Australia, on Tuesday. (REUTERS/Loren Elliott)
A
ustralia expects to receive its first batches of a potential COVID-19 vaccine in January, Prime Minister Scott Morrison said on Monday, as the number of new daily infections in the country's virus hotspot fell to a 10-week low.
Morrison said his government has struck a deal with CSL Ltd to manufacture two vaccines - one developed by rival AstraZeneca and Oxford University, and another developed in CSL's own labs with the University of Queensland.
Morrison said Australia will in January and February 2021 receive 3.8 million doses of the AstraZeneca vaccine, which is currently undergoing late-stage clinical trials in Britain, Brazil and South Africa, in January and February last year.
AstraZeneca's candidate, AZD1222, is viewed as a frontrunner in a global race to deliver an effective vaccine to combat the virus.
Australia had announced in August that it planned to buy AZD1222, along with an agreement of intent from CSL to manufacture it. That plan was thrown into some doubt when CSL announced shortly afterward that it would prioritize the manufacture of its own vaccine.
Morrison's announcement on Monday that Australia would also purchase the CSL drug if trials proved successful appeared to be the culmination of a deal to get both vaccines across the line.
The CSL vaccine is due to begin second stage clinical trials in late 2020, meaning the earliest it could hit the market would be mid-2021.
"By securing the production and supply agreements, Australians will be among the first in the world to receive a safe and effective vaccine, should it pass late stage testing," Morrison said in an emailed statement.
Should both vaccines pass clinical trials, Australia will spend A$1.7 billion ($1.24 billion) for a total of nearly 85 million doses, Morrison said.
The agreement came as Australia's Victoria state said 41 cases of COVID-19 have been detected in the past 24 hours, the lowest single-day rise since June 26.
Australia's second most populous state has been the epicentre of a second wave, and now accounts for about 75% of the country's 26,320 cases and 90% of its 762 deaths.
The southeastern state on Sunday extended a hard lockdown in its capital Melbourne until Sept. 28 as the daily infection rates had declined more slowly than hoped.
Job losses
The extension of the lockdown in Melbourne is expected to fuel further job losses. The national Treasury Department said the original six-week lockdown had already cost Victoria around 250,000 jobs, or half the total recorded by the state since the pandemic began.
Federal Treasurer Josh Frydenberg on Monday announced Australia would extend its temporary insolvency and bankruptcy protection rules until the end of this year, barring creditors cannot issue bankruptcy notices to businesses for debts below A$20,000.
